Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Just-evotec Biologics

Clinical trials sponsored by Just-evotec Biologics, explained in plain language.

Now part of Evotec SE EVT XETRA

Biologics contract development and manufacturing, subsidiary of Evotec.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 1

New antibody combo JST-018 enters first human safety trial

Disease control Recruiting now

This Phase 1 study is testing whether a single injection of JST-018, a mix of three monoclonal antibodies, is safe and tolerable in 48 healthy adults aged 18 to 55. Participants will be monitored for side effects, drug levels in the blood, and immune responses over one year. This…

Phase: PHASE1 • Sponsor: Just-Evotec Biologics • Aim: Disease control

Last updated Aug 07, 2026 00:00 UTC